суббота, 20 ноября 2010 г.

Synthesis of tert-butyl (1H-benzo[d]imidazol-2-yl)methylcarbamate.





tert-Butyl (1H-benzo[d]imidazol-2-yl)methylcarbamate.
Benzene-1, 2-diamine (1.05 g, 9.72 mmol) and N-(tert-butoxycarbonyl)glycine (1.71 g, 9.72 mmol) were dissolved in 30 ml of THF and cooled to 0 °C. Into the above solution was added N, N'-dicyclohexylcarbodiimide (2.41 g, 11.7 mmol ) in batches and the mixture was stirred at 0 °C for half an hour and then at room temperature overnight. The reaction mixture was filtrated and evaporated to afford a brown oil, which was purified by a silica-gel column chromatography (dichloromethane / methanol, 25:1 by volume) to get a yellow solid (2.24 g). The solid was dissolved in 20 ml of acetic acid and the solution was stirred at 72 °C for 8 h. The acetic acid was removed under reduced pressure and the crude compound was purified by a silica-gel column chromatography (dichloromethane / methanol, 25:1 by volume) to afford a white solid. Yield: 82%. m.p. 181-183 °C. IR (KBr) cm-1: 3343 (-NH-), 3058, 2980, 2940 (CH, aliphatic), 1686 (>C=O), 1529 (-C=C-), 736 (-Ar-); 1H NMR (300 MHz, CDCl3, δ ppm): 1.45 (s, 9H, CH3), 4.53-4.55 (d, 2H, J = 6.3 Hz, CH2), 6.12 (brs, 1H, NH), 7.22-7.25 (m, 2H, Ar-H), 7.54-7.60 (m, 2H, Ar-H); HRMS (ESI): [M + H]+ calcd m/z 248.1400, found 248.1397.δ ppm): 1.45 (s, 9H, CH3), 4.53-4.55 (d, 2H, J = 6.3 Hz, CH2), 6.12 (brs, 1H, NH), 7.22-7.25 (m, 2H, Ar-H), 7.54-7.60 (m, 2H, Ar-H); HRMS (ESI): [M + H]+ calcd m/z 248.1400, found 248.1397.

Комментариев нет:

Отправить комментарий

Ярлыки

акситиниб (1) Бринатиниб (1) ваталаниб (1) Гефитиниб (1) гливек (1) дазатиниб (2) данусертиб (1) зактима (1) икотиниб (1) карнетиниб (1) Кризотиниб (1) куизартиниб (1) лапатиниб (1) лекарства (1) лекарство (1) линифаниб (1) Маситиниб (1) нексавар (1) понатиниб (1) руксолитиниб (1) сорафениб (1) спрайсел (2) Сунитиниб (2) сутент (1) тайверб (1) тандуниб (1) Тарцева (2) Цедираниб (1) Эрлотиниб (2) AB1010 (1) ABT-869 (1) Afatinib (2) AG-013736 (1) ALK-kinase (1) AMG-706 (1) AP24534 (1) Apatinib (1) Armala (1) AV-951 (1) axinitib (1) AZD-0530 (1) AZD2171 (2) Bafenitib (1) Bafetinib (2) BAY 73-4506 (1) BIBW 2992 (1) BMS-540215 (2) bosutinib (2) Brivanib (2) canertinib (1) Cediranib (2) CEP-701 (1) CHIR258 (1) CP690550 (1) Crizotinib (1) danusertib (1) Dasatinib (2) Dovitinib (1) Erlotinib (1) Foretinib (1) Gefinitib (1) Gefitinib (2) gleevec (1) Gold reagent (1) HKI 272 (1) Icotinib (1) imatinib (1) INNO-406 (2) Iressa (1) lapatinib (2) lestaurtinib (1) linifanib (1) Masitinib (1) MLN 518 (1) Mubritinib (2) Nexavar (2) nilotinib (1) NS-187 (2) OSI-774 (1) Palladia (1) Pazopanib (2) Pelitinib (1) PF-02341066 (1) PHA-739358 (1) Ponatinib (1) pyrazole (1) Recentin (2) Regorafenib (1) Ruxolitinib (1) Saracatinib (2) sc-202353 (1) Silimitasertib (1) SKI-606 (2) Sorafenib (2) Sorafenib tosylate (1) Sprycel (2) Sunitinib (2) Sunitinib Malate (2) Sutent (2) Tarceva (2) targeted agents (1) tasigna (1) Tasocitinib (1) Tivozanib (1) TKI-258 (1) toceranib (1) Tovok (2) tykerb (2) tyverb (1) vandetanib (1) Vatalanib (1) Votrient (2) YN968D1 (1) zactima (1) ZD6474 (1) 凡德他尼 (1) 尼罗替尼 (1) 阿西替尼 (1)